Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Amivantamab (JNJ-61186372) is a bispecific antibody targeting EGFR-MET with immune anticancer properties. It prevents ligand binding, enhances receptor-antibody complex endocytosis and degradation, and triggers Fc-mediated macrophage cytokinesis and natural killer cell antibody-dependent cytotoxicity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Amivantamab (JNJ-61186372) is a bispecific antibody targeting EGFR-MET with immune anticancer properties. It prevents ligand binding, enhances receptor-antibody complex endocytosis and degradation, and triggers Fc-mediated macrophage cytokinesis and natural killer cell antibody-dependent cytotoxicity [1]. |
Molecular Weight | N/A |
CAS No. | 2171511-58-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Amivantamab 2171511-58-1 inhibitor inhibit